Kiniksa Pharmaceuticals International, PLC (KNSA) — 10-Q Filings

10-Q Filings (6)

• Kiniksa Swings to Profit on 61% ARCALYST Revenue Jump — Oct 28, 2025 Risk: medium
  Kiniksa Pharmaceuticals International, plc reported a significant financial turnaround for the three and nine months ended September 30, 2025. Product revenue,
• Kiniksa's Q2 Net Loss Widens to $43.4M Amid Rising Expenses — Jul 29, 2025 Risk: high
  Kiniksa Pharmaceuticals International, plc reported a net loss of $43.4 million for the three months ended June 30, 2025, a significant increase from the $37.6
• Kiniksa Pharmaceuticals Q1 2025 Update — Apr 29, 2025 Risk: low
  Kiniksa Pharmaceuticals International, plc filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates
• Kiniksa Pharma Files Q3 2024 10-Q — Oct 29, 2024 Risk: low
  Kiniksa Pharmaceuticals International, plc filed its 10-Q for the period ending September 30, 2024. The filing details the company's financial position, includi
• Kiniksa Pharmaceuticals Q2 2024 Update — Jul 25, 2024 Risk: medium
  Kiniksa Pharmaceuticals International, plc filed its 10-Q for the period ending June 30, 2024. The company reported significant financial figures, including $16
• Kiniksa Pharmaceuticals, Ltd. Files 10-Q for Period Ending March 31, 2024 — Apr 25, 2024 Risk: low
  Kiniksa Pharmaceuticals, Ltd. (KNSA) filed a Quarterly Report (10-Q) with the SEC on April 25, 2024. Kiniksa Pharmaceuticals, Ltd. filed a 10-Q report for the p

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX